EQUASENS (EQS.PA) Fundamental Analysis & Valuation

EPA:EQS • FR0012882389

Current stock price

39.55 EUR
-0.95 (-2.35%)
Last:

This EQS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. EQS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EQS was profitable.
  • EQS had a positive operating cash flow in the past year.
  • EQS had positive earnings in each of the past 5 years.
  • In the past 5 years EQS always reported a positive cash flow from operatings.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • The Return On Assets of EQS (8.82%) is comparable to the rest of the industry.
  • EQS has a better Return On Equity (15.77%) than 83.33% of its industry peers.
  • EQS has a Return On Invested Capital of 12.84%. This is amongst the best in the industry. EQS outperforms 100.00% of its industry peers.
  • EQS had an Average Return On Invested Capital over the past 3 years of 15.18%. This is significantly above the industry average of 7.44%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • EQS has a better Profit Margin (16.13%) than 75.00% of its industry peers.
  • EQS's Profit Margin has been stable in the last couple of years.
  • EQS has a Operating Margin of 20.02%. This is amongst the best in the industry. EQS outperforms 83.33% of its industry peers.
  • EQS's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 68.81%, EQS perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. EQS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
  • The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
  • EQS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EQS has been reduced compared to a year ago.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • EQS has an Altman-Z score of 3.86. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
  • EQS has a Altman-Z score of 3.86. This is in the better half of the industry: EQS outperforms 66.67% of its industry peers.
  • EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
  • EQS has a better Debt to FCF ratio (0.98) than 66.67% of its industry peers.
  • EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.09, EQS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.86
ROIC/WACC1.67
WACC7.7%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Current ratio (1.29) which is in line with its industry peers.
  • A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
  • EQS has a Quick ratio of 1.20. This is comparable to the rest of the industry: EQS outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. EQS.PA Growth Analysis

3.1 Past

  • EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.90%.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
  • Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.34% on average over the next years. This is quite good.
  • EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y9.47%
EPS Next 2Y15.15%
EPS Next 3Y13.96%
EPS Next 5Y14.34%
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

6

4. EQS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.48, the valuation of EQS can be described as correct.
  • Based on the Price/Earnings ratio, EQS is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • EQS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
  • The Price/Forward Earnings ratio is 13.01, which indicates a correct valuation of EQS.
  • Based on the Price/Forward Earnings ratio, EQS is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, EQS is valued a bit cheaper.
Industry RankSector Rank
PE 16.48
Fwd PE 13.01
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EQS is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
  • 66.67% of the companies in the same industry are more expensive than EQS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.08
EV/EBITDA 8.2
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EQS has a very decent profitability rating, which may justify a higher PE ratio.
  • EQS's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.74
PEG (5Y)3.22
EPS Next 2Y15.15%
EPS Next 3Y13.96%

6

5. EQS.PA Dividend Analysis

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.41%.
  • EQS's Dividend Yield is comparable with the industry average which is at 2.34.
  • EQS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

  • On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years0
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EQS pays out 51.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.82%
EPS Next 2Y15.15%
EPS Next 3Y13.96%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

EQS.PA Fundamentals: All Metrics, Ratios and Statistics

EQUASENS

EPA:EQS (4/24/2026, 7:00:00 PM)

39.55

-0.95 (-2.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-30
Earnings (Next)04-29
Inst Owners12.32%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap599.97M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (36.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 16.48
Fwd PE 13.01
P/S 2.67
P/FCF 16.08
P/OCF 12.3
P/B 2.61
P/tB 7.51
EV/EBITDA 8.2
EPS(TTM)2.4
EY6.07%
EPS(NY)3.04
Fwd EY7.69%
FCF(TTM)2.46
FCFY6.22%
OCF(TTM)3.22
OCFY8.13%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.74
PEG (5Y)3.22
Graham Number28.6111 (-27.66%)
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.86
F-Score7
WACC7.7%
ROIC/WACC1.67
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y9.47%
EPS Next 2Y15.15%
EPS Next 3Y13.96%
EPS Next 5Y14.34%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year58.15%
EBIT Next 3Y25.89%
EBIT Next 5Y22.65%
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.


How profitable is EQUASENS (EQS.PA) stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


What is the valuation of EQUASENS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 16.48 and the Price/Book (PB) ratio is 2.61.


Is the dividend of EQUASENS sustainable?

The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.82%.